DELTA XTEND Reverse Shoulder System
510(k) K203694
Active
Valid until
Not listed
FDA recalls
None foundTrust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE 510(k) | NumberK203694 | Date22 Jul 2021 | StatusActive |
| European Union | CE/MDR EUDAMED | Number— | Date— | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- 510(k) Number
- FDA Product Code
- PHX
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3660
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Delta XTEND Reverse Shoulder System is a reverse shoulder arthroplasty device designed for the replacement of the shoulder joint in patients with conditions such as rotator cuff arthropathy, severe osteoarthritis, or post-traumatic arthritis. It features a reverse ball-and-socket design to restore function and stability by transferring the deltoid muscle’s force to the humeral component, enabling improved mobility for the patient.
This system is supplied as a sterile, single-use orthopedic implant intended for surgical use in certified orthopedic operating rooms. It is available in various component sizes to accommodate different anatomical requirements and is regulated under FDA 510(k) clearance and MDR compliance. Proper handling, storage, and adherence to manufacturer guidelines are essential to ensure sterility and functionality prior to implantation.